ATI-045

· Aclaris Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATI-045, covering 2026-03-25 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis [Phase 2]